Article
Involvement of Protective Autophagy in TRAIL Resistance of Apoptosis-defective Tumor Cells
29 Mar 2008
Abstract excerpt
Targeting TRAIL receptors with either recombinant TRAIL or agonistic DR4- or DR5-specific antibodies has been considered a promising treatment for cancer, particularly due to the preferential apoptotic susceptibility of tumor cells over normal cells to TRAIL. However, the realization that many tumors are unresponsive to TRAIL treatment has stimulated interest in identifying apoptotic agents that when used in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
